327 related articles for article (PubMed ID: 30632713)
1. Fatigue, symptom burden, and health-related quality of life in patients with myelodysplastic syndrome, aplastic anemia, and paroxysmal nocturnal hemoglobinuria.
Escalante CP; Chisolm S; Song J; Richardson M; Salkeld E; Aoki E; Garcia-Manero G
Cancer Med; 2019 Feb; 8(2):543-553. PubMed ID: 30632713
[TBL] [Abstract][Full Text] [Related]
2. [Anemia with aplastic anemia, paroxysmal nocturnal hemoglobinuria and myelodysplastic syndromes].
Passweg JR
Ther Umsch; 2010 May; 67(5):251-5. PubMed ID: 20509122
[TBL] [Abstract][Full Text] [Related]
3. Development of a disease-specific quality of life questionnaire for patients with aplastic anemia and/or paroxysmal nocturnal hemoglobinuria (QLQ-AA/PNH)-report on phases I and II.
Groth M; Singer S; Niedeggen C; Petermann-Meyer A; Röth A; Schrezenmeier H; Höchsmann B; Brümmendorf TH; Panse J
Ann Hematol; 2017 Feb; 96(2):171-181. PubMed ID: 27837250
[TBL] [Abstract][Full Text] [Related]
4. N-RAS gene mutation in patients with aplastic anemia and aplastic anemia/ paroxysmal nocturnal hemoglobinuria during evolution to clonal disease.
Mortazavi Y; Tooze JA; Gordon-Smith EC; Rutherford TR
Blood; 2000 Jan; 95(2):646-50. PubMed ID: 10627475
[TBL] [Abstract][Full Text] [Related]
5. [Expression of three kinds of GPI-anchor proteins in paroxysmal nocturnal hemoglobinuria, aplastic anemia and myelodysplastic syndromes patients and their clinical implications].
Dong XY; Xu CG; Sun GR; Zhang T; Peng J
Zhonghua Xue Ye Xue Za Zhi; 2004 Apr; 25(4):198-201. PubMed ID: 15182554
[TBL] [Abstract][Full Text] [Related]
6. Clinical and prognostic significance of small paroxysmal nocturnal hemoglobinuria clones in myelodysplastic syndrome and aplastic anemia.
Fattizzo B; Ireland R; Dunlop A; Yallop D; Kassam S; Large J; Gandhi S; Muus P; Manogaran C; Sanchez K; Consonni D; Barcellini W; Mufti GJ; Marsh JCW; Kulasekararaj AG
Leukemia; 2021 Nov; 35(11):3223-3231. PubMed ID: 33664463
[TBL] [Abstract][Full Text] [Related]
7. Increased frequency of HLA-DR2 in patients with paroxysmal nocturnal hemoglobinuria and the PNH/aplastic anemia syndrome.
Maciejewski JP; Follmann D; Nakamura R; Saunthararajah Y; Rivera CE; Simonis T; Brown KE; Barrett JA; Young NS
Blood; 2001 Dec; 98(13):3513-9. PubMed ID: 11739151
[TBL] [Abstract][Full Text] [Related]
8. Standardized high-sensitivity flow cytometry testing for paroxysmal nocturnal hemoglobinuria in children with acquired bone marrow failure disorders: A single center US study.
Donohue RE; Marcogliese AN; Sasa GS; Elghetany MT; Redkar AA; Bertuch AA; Curry CV
Cytometry B Clin Cytom; 2018 Jul; 94(4):699-704. PubMed ID: 28574201
[TBL] [Abstract][Full Text] [Related]
9. Design and development of a disease-specific quality of life tool for patients with aplastic anaemia and/or paroxysmal nocturnal haemoglobinuria (QLQ-AA/PNH)-a report on phase III.
Niedeggen C; Singer S; Groth M; Petermann-Meyer A; Röth A; Schrezenmeier H; Höchsmann B; Brümmendorf TH; Panse J
Ann Hematol; 2019 Jul; 98(7):1547-1559. PubMed ID: 31115593
[TBL] [Abstract][Full Text] [Related]
10. High frequency of several PIG-A mutations in patients with aplastic anemia and myelodysplastic syndrome.
Okamoto M; Shichishima T; Noji H; Ikeda K; Nakamura A; Akutsu K; Maruyama Y
Leukemia; 2006 Apr; 20(4):627-34. PubMed ID: 16467865
[TBL] [Abstract][Full Text] [Related]
11. A prospective multicenter study of paroxysmal nocturnal hemoglobinuria cells in patients with bone marrow failure.
Raza A; Ravandi F; Rastogi A; Bubis J; Lim SH; Weitz I; Castro-Malaspina H; Galili N; Jawde RA; Illingworth A
Cytometry B Clin Cytom; 2014 May; 86(3):175-82. PubMed ID: 24227693
[TBL] [Abstract][Full Text] [Related]
12. Comparison of High Sensitivity and Conventional Flow Cytometry for Diagnosing Overt Paroxysmal Nocturnal Hemoglobinuria and Detecting Minor Paroxysmal Nocturnal Hemoglobinuria Clones.
Park SH; Jeong J; Lee SH; Yoo DW; Choi Y; Jo JC; Lim JH
Ann Lab Med; 2019 Mar; 39(2):150-157. PubMed ID: 30430777
[TBL] [Abstract][Full Text] [Related]
13. [Clonal hematopoiesis in aplastic anemia and paroxysmal nocturnal hemoglobinuria].
Makishima H
Rinsho Ketsueki; 2022; 63(9):1042-1045. PubMed ID: 36198527
[TBL] [Abstract][Full Text] [Related]
14. Long-term follow-up of clonal evolutions in 802 aplastic anemia patients: a single-center experience.
Li Y; Li X; Ge M; Shi J; Qian L; Zheng Y; Wang J
Ann Hematol; 2011 May; 90(5):529-37. PubMed ID: 21207031
[TBL] [Abstract][Full Text] [Related]
15. Paroxysmal nocturnal hemoglobinuria testing in patients with myelodysplastic syndrome in clinical practice-frequency and indications.
Wong SA; Dalal BI; Leitch HA
Curr Oncol; 2018 Oct; 25(5):e391-e397. PubMed ID: 30464689
[TBL] [Abstract][Full Text] [Related]
16. Two cases showing clonal progression with full evolution from aplastic anemia-paroxysmal nocturnal hemoglobinuria syndrome to myelodysplastic syndromes and leukemia.
Ishihara S; Nakakuma H; Kawaguchi T; Nagakura S; Horikawa K; Hidaka M; Asou N; Mitsuya H
Int J Hematol; 2000 Aug; 72(2):206-9. PubMed ID: 11039670
[TBL] [Abstract][Full Text] [Related]
17. Eculizumab for treating patients with paroxysmal nocturnal hemoglobinuria.
Martí-Carvajal AJ; Anand V; Cardona AF; Solà I
Cochrane Database Syst Rev; 2014 Oct; (10):CD010340. PubMed ID: 25356860
[TBL] [Abstract][Full Text] [Related]
18. Aplastic Anemia & MDS International Foundation (AA&MDSIF): bone marrow failure disease scientific symposium 2012.
Savage SA; Pulsipher MA; Romano A; Berlyne D
Leuk Res; 2013 Jul; 37(7):848-51. PubMed ID: 23643149
[TBL] [Abstract][Full Text] [Related]
19. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Sun L; Babushok DV
Blood; 2020 Jul; 136(1):36-49. PubMed ID: 32430502
[TBL] [Abstract][Full Text] [Related]
20. Relationship between aplastic anemia and paroxysmal nocturnal hemoglobinuria.
Kinoshita T; Inoue N
Int J Hematol; 2002 Feb; 75(2):117-22. PubMed ID: 11939256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
